The scientist’s investigation covers issues in Muscular dystrophy, Magnetic resonance imaging, Pediatrics, Pathology and Physical therapy. Eugenio Mercuri interconnects Limb-girdle muscular dystrophy, Mutation and Duchenne muscular dystrophy in the investigation of issues within Muscular dystrophy. His Magnetic resonance imaging research is multidisciplinary, relying on both Central nervous system disease and Anatomy.
Eugenio Mercuri has researched Pediatrics in several fields, including Hypoxic Ischemic Encephalopathy, Neonatal encephalopathy, Cerebral palsy and Neurological disorder. His Pathology research also works with subjects such as
His primary areas of study are Pediatrics, Duchenne muscular dystrophy, Spinal muscular atrophy, Physical therapy and Internal medicine. His study explores the link between Pediatrics and topics such as Cohort that cross with problems in Longitudinal study. Eugenio Mercuri studied Duchenne muscular dystrophy and Muscular dystrophy that intersect with Pathology, Anatomy and Missense mutation.
His work on SMN1 as part of general Spinal muscular atrophy research is frequently linked to Nusinersen, thereby connecting diverse disciplines of science. His study looks at the intersection of Physical therapy and topics like Physical medicine and rehabilitation with Rasch model. His studies deal with areas such as Endocrinology, Surgery and Cardiology as well as Internal medicine.
Spinal muscular atrophy, Pediatrics, Internal medicine, Nusinersen and Duchenne muscular dystrophy are his primary areas of study. His Spinal muscular atrophy study combines topics in areas such as Clinical trial, Cohort and Intensive care medicine. The Cohort study which covers Cohort study that intersects with Age of onset.
His Pediatrics research focuses on Natural history and how it connects with CHOP. His Respiratory function, Retrospective cohort study and Respiratory system study, which is part of a larger body of work in Internal medicine, is frequently linked to Repeated measures design, bridging the gap between disciplines. His work on Dystrophin as part of general Duchenne muscular dystrophy research is frequently linked to In patient, thereby connecting diverse disciplines of science.
Eugenio Mercuri mainly investigates Spinal muscular atrophy, Nusinersen, Cohort, Internal medicine and Pediatrics. His Spinal muscular atrophy study combines topics from a wide range of disciplines, such as Clinical trial and Cohort study. His Cohort research focuses on CHOP and how it relates to Natural history, Neonatal onset, Severity of illness and After treatment.
His work on Duchenne muscular dystrophy, Respiratory function, Randomized controlled trial and Breathing as part of his general Internal medicine study is frequently connected to In patient, thereby bridging the divide between different branches of science. The various areas that Eugenio Mercuri examines in his Pediatrics study include Observational study, Young adult, Muscle biopsy, Rhabdomyolysis and Spinal muscular atrophy type II. His studies examine the connections between Pathology and genetics, as well as such issues in Skeletal muscle, with regards to Limb-girdle muscular dystrophy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Richard S. Finkel;Eugenio Mercuri;Basil T. Darras;Anne M. Connolly.
The New England Journal of Medicine (2017)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Eugenio Mercuri;Basil T. Darras;Claudia A. Chiriboga;John W. Day.
The New England Journal of Medicine (2018)
Origin and timing of brain lesions in term infants with neonatal encephalopathy
Frances Cowan;Mary Rutherford;Floris Groenendaal;Paula Eken.
The Lancet (2003)
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
Martin Brockington;Derek J. Blake;Paola Prandini;Susan C. Brown.
American Journal of Human Genetics (2001)
Clinical and molecular genetic spectrum of autosomal dominant Emery‐Dreifuss muscular dystrophy due to mutations of the lamin A/C gene
Bonne G;Mercuri E;Muchir A;Urtizberea A.
Annals of Neurology (2000)
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.
Eugenio Mercuri;Richard S Finkel;Francesco Muntoni;Brunhilde Wirth.
Neuromuscular Disorders (2017)
Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.
Jerry R. Mendell;Nathalie Goemans;Linda P. Lowes;Lindsay N. Alfano.
Annals of Neurology (2016)
Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy
M. A. Rutherford;J. M. Pennock;S. J. Counsell;E. Mercuri.
Ataluren treatment of patients with nonsense mutation dystrophinopathy
Katharine Bushby;Richard Finkel;Brenda Wong;Richard Barohn.
Muscle & Nerve (2014)
Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
Caroline Godfrey;Emma Clement;Rachael Mein;Martin Brockington.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: